Biomarkers of early chronic obstructive pulmonary disease (COPD) in smokers and former smokers. Protocol of a longitudinal study.
(2016) In Clinical and Translational Medicine 5(1).- Abstract
- Chronic obstructive pulmonary disease (COPD) is an irreversible disease, diagnosed predominantly in smokers. COPD is currently the third leading cause of death worldwide. Far more than 15 % of smokers get COPD: in fact, most develop some amount of pulmonary impairment. Smoking-related COPD is associated with both acute exacerbations and is closely correlated to comorbidities, such as cardiovascular disease and lung cancer. The objective of our study (KOL-Örestad) is to identify biomarkers in smokers and ex-smokers, with early signs of COPD, and compare these biomarkers with those of non-smokers and healthy smokers/ex-smokers. The participants in the study are recruited from Örestadskliniken, a primary health care clinic in Malmö, Sweden.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8853122
- author
- Truedsson, Mikael ; Malm, Johan LU ; Sahlin, Barbara LU ; Bugge, May ; Wieslander, Elisabet LU ; Dahlbäck, Magnus LU ; Appelqvist, Roger LU ; Fehniger, Thomas LU and Marko-Varga, György LU
- organization
- publishing date
- 2016
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Clinical and Translational Medicine
- volume
- 5
- issue
- 1
- article number
- 9
- publisher
- Wiley
- external identifiers
-
- pmid:26951192
- pmid:26951192
- wos:000391945700002
- ISSN
- 2001-1326
- DOI
- 10.1186/s40169-016-0086-5
- language
- English
- LU publication?
- yes
- id
- 590a7cf4-8810-4be1-9fba-557e9ed1b1ff (old id 8853122)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26951192?dopt=Abstract
- date added to LUP
- 2016-04-04 09:29:55
- date last changed
- 2018-11-21 20:53:31
@article{590a7cf4-8810-4be1-9fba-557e9ed1b1ff, abstract = {{Chronic obstructive pulmonary disease (COPD) is an irreversible disease, diagnosed predominantly in smokers. COPD is currently the third leading cause of death worldwide. Far more than 15 % of smokers get COPD: in fact, most develop some amount of pulmonary impairment. Smoking-related COPD is associated with both acute exacerbations and is closely correlated to comorbidities, such as cardiovascular disease and lung cancer. The objective of our study (KOL-Örestad) is to identify biomarkers in smokers and ex-smokers, with early signs of COPD, and compare these biomarkers with those of non-smokers and healthy smokers/ex-smokers. The participants in the study are recruited from Örestadskliniken, a primary health care clinic in Malmö, Sweden.}}, author = {{Truedsson, Mikael and Malm, Johan and Sahlin, Barbara and Bugge, May and Wieslander, Elisabet and Dahlbäck, Magnus and Appelqvist, Roger and Fehniger, Thomas and Marko-Varga, György}}, issn = {{2001-1326}}, language = {{eng}}, number = {{1}}, publisher = {{Wiley}}, series = {{Clinical and Translational Medicine}}, title = {{Biomarkers of early chronic obstructive pulmonary disease (COPD) in smokers and former smokers. Protocol of a longitudinal study.}}, url = {{http://dx.doi.org/10.1186/s40169-016-0086-5}}, doi = {{10.1186/s40169-016-0086-5}}, volume = {{5}}, year = {{2016}}, }